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Abstract: 
Combining organometallics and biology has generated broad interest from scientists working on 
applications from in situ drug release to biocatalysis. Engineered enzymes and biohybrid catalysts 
(also referred to as artificial enzymes) have introduced a wide range of abiotic chemistry into 
biocatalysis. Predominantly, this work has concentrated on using these catalysts for single step in 
vitro reactions. However, the promise of using these hybrid catalysts in vivo and combining them 
with synthetic biology and metabolic engineering is vast. This report will briefly review recent 
advances in artificial metalloenzyme design, followed by summarising recent studies that have 
looked at the use of these hybrid catalysts in vivo and in enzymatic cascades, therefore exploring 
their potential for synthetic biology.  
1.1 Engineered metalloenzymes and enzyme hybrids for catalysis 
1.1.1 Recent Advances 
Over the last 20 years there have been two main approaches to designing novel metalloenzymes, a) 
the engineering of natural metalloenzymes to perform new-to-nature reactions or b) introducing 
synthetic metal complexes into protein scaffolds to create new abiotic active sites, often referred to 
as biohybrid catalysts or artificial metalloenzymes (ArMs). Several reviews have been recently 
published on both engineered metalloenzymes and artificial metalloenzymes covering their design 
and applications [1-4], therefore the examples below focus on reports from the last 3 years.  
Metalloenzymes are nature’s organometallic reagents, using metal cofactors to control reactions 
and expand the range of chemistry that the 20 canonical amino acids can perform. By taking 
advantage of the small amounts of promiscuity that some metalloenzymes possess, chemists have 
engineered these enzymes to perform new-to-nature reactions. The majority of work has focused on 
using directed evolution to expand the chemistry of heme enzymes including P450s, cytochrome cs, 
and myoglobins (Mb) to utilise metal carbene and nitrene intermediates, making a whole range of 
molecules from bicyclobutanes to organosilanes [1,5]. Recent work has pushed this further adding 
borylation [6-8] to S-H, N-H and Si-H insertions, as well as broadening the scope of carbene [9-11] 
and nitrene insertions [12,13]. Following the success of engineered heme enzymes in abiotic 
reactions, non-heme enzymes have been investigated as a starting platform. One of the benefits of 
non-heme enzymes is that they have multiple open coordination sites available for substrates, which 
unleashes the possibility of catalysing transition metal reactions that utilise mechanisms with two 
metal bound substrates e.g. oxidative addition/reductive elimination processes. Arnold and co-
workers showed that the α-ketoglutarate (αKG)-dependent iron enzyme Pseudomonas savastanoi 
ethylene-forming enzyme (PsEFE) can catalyse nitrene azridination and C-H amination using sulfonyl 
azides as nitrene precursors [14]. Initial studies on halogenases also show they have promise as 




Alongside genetic engineering of natural proteins, chemical optimisation by replacing the natural 
metal cofactor with an alternative metal has been explored, e.g. replacing heme in Mb or P450 with 
Ir(Me)(PIX) or Co(PIX) (PIX: protoporphyrin IX )[17,18] or copper with osmium in a thermostable 
cupin [19]. Initial results with the Ir-reconstituted heme proteins showed they catalysed more 
challenging carbene and nitrene transfer reactions than engineered hemoproteins [17]. However, 
further evolution of P450s has since meant that Fe-heme enzymes have caught up with these 
artificial constructs, highlighting the extraordinary power of directed evolution [20]. 
The engineering of natural metalloenzymes for abiotic reactions is limited to reactions occurring by 
similar mechanisms to those observed in the natural enzyme. Artificial metalloenzymes in contrast 
allow numerous reactions with no natural precedent to be introduced into the biocatalytic toolbox.i 
The most popular reactions; Diels-Alder and Friedel-Crafts reactions (Figure 1A), asymmetric 
hydrogenation (Figure 1B), and alkene metathesis; have become benchmark reactions for the 
screening of new ArMs and still dominate the literature [2, 21, 22].  Nevertheless, many different 
reactions have been targeted by chemists looking to develop more sustainable catalysts that utilise 
water as a solvent, low temperatures and allow metal recycling (see Figure 1C-E for examples) [23-
27]. ArMs have also begun to provide solutions for reactions where small molecule catalysts have 
not achieved the desired selectivity [28,29].  
 
Figure 1: A and B: Common benchmark reactions for ArMs listing the different protein scaffolds used 
in these reactions. Examples of reactions catalysed by ArMs: C: Biphasic Rh-catalysed 
hydroformylation [24], D: Asymmetric lactam formation [26], E: Cu-catalysed asymmetric enone 
hydration [28].  
                                                          
i A useful resource for those looking to search for reported ArMs is the database of ArMs published and 
updated by the Ward group (URL: https://amp.ward-lab.ch/), see ref. [2]. 
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1.1.2 Designing artificial metalloenzymes 
The basic design principles of ArMs are the choice of a metal centre for a target reaction, and a 
protein scaffold to control selectivity. Numerous different scaffolds have been chosen over the years 
for the design of ArMs (see Figure 1 for examples), and successful scaffolds are often applied in 
many different reactions highlighting their versatility and generality. Of note is the lactococcal 
multidrug resistance regulator (LmrR) scaffold, which has been modified by several different binding 
methods including covalent binding through cysteine, supramolecular ligand binding, and by 
introducing unnatural amino acids [30,31]. This versatility, in combination with its application for 
multiple chemical reactions, suggests LmrR can be viewed as a ‘privileged protein scaffold’. The most 
recent additions to the scaffolds applied in ArM design were chosen for their specific biological 
features e.g. CeuE, an iron-siderophore periplasmic binding protein, was utilised by the Duhme-Klair 
group to introduce a redox switchable anchor for metal complex recovery [32]. Whilst Arold, Groll, 
Eppinger and co-workers mutated monomeric Clavularia cyan fluorescent protein (mTFP*) to allow 
the quantification of metal binding using tmFRET titration experiments [33]. 
 
Figure 2: A: Organocatalytic and metal-catalysed cooperative sites in a designed ArM [34], B: An ArM 
containing two active sites for sequential catalysis [35].  
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The power of ArM design was showcased in recent reports that introduced two active sites to an 
ArM either to bind and activate a substrate or to enable a cascade reaction. In 2020, Roelfes and 
Zhou reported an ArM that combined both the supramolecular binding of a catalytically active Cu-
phen complex with the addition of an unnatural amino acid p-aminophenyl alanine (pAF) (Figure 2A) 
[34]. The pAF was incorporated to bind and activate the enal substrate towards nucleophilic attack 
of the copper-bound enolate. Ferrer, Guallar, Sanz-Aparicio and co-workers described the design of 
an ArM containing two active sites, Figure 2B [35]. The natural biocatalyst EH1A1 was converted into 
an ArM by using a metal complex attached to a phosphonate suicide inhibitor. Protein Energy 
Landscape Exploration (PELE) software was then applied to introduce a second binding pocket with a 
biologically active site (an ester hydrolase site). The resulting dual site ArM, EH1AB1, catalysed ester 
hydrolysis followed by either a Cu-catalysed oxidation or a Friedel-Crafts alkylation with excellent 
conversions and enantioselectivities. 
One of the major goals for the protein design community is the de novo design of functional 
proteins. Obtaining functional metalloproteins from first principles is challenging. Initial catalytic 
reports were limited to reactions catalysed by native metalloenzymes (oxidation, hydrolysis) and 
used substrates of limited synthetic utility [36-38]. A recent report by Anderson and co-workers 
showed that de novo metalloproteins can catalyse abiotic reactions of synthetically attractive 
substrates. They used a thermostable heme maquette C45 to catalyse a range of carbene transfer 
reactions [39].  Taken together these recent reports highlight an increasing ability to rationally 
design metalloenzymes for catalysis.  
1.2 Merging synthetic biology and metalloenzymes for catalysis 
1.2.1 Moving from in vitro to in vivo catalysis 
Metalloenzymes engineered from natural metalloenzymes and de novo designed proteins that use 
the dative binding of metals to amino acids or natural metal complexes, such as heme, are 
inherently able to be used in vivo. This has enabled them to be optimised quickly using methods 
such as directed evolution leading to highly active catalysts. Additionally, whole cells can act as 
compartments which isolate metalloenzymes from starting materials, providing opportunities for 
the synthesis of reactive reagents in situ [9]. For these reasons, and to enable the use of ArMs in 
biosynthetic pathways, it is desirable to design ArMs that can be used in vivo.  
The recent advances in molecular biology and synthetic biology have provided many different tools 
to design catalysts for use within cells. For example, the promiscuous ChuA transport protein was 
shown to transport Ir(Me)(DPIX) (DPIX: deuteroporphyrin IX) into cells. The heme-binding pocket of 
a P450 was engineered so it would preferentially accept Ir(Me)(DPIX) over heme. This enabled 
Ir(Me)-containing P450 variants to be directly expressed in vivo [40]. In comparison ArMs created 
using the covalent modification of cysteine with a metal complex are more complicated to move to 
in vivo systems. Challenges to overcome include the need to purify the protein before modification 
thus removing competitive thiols and the avoidance of catalyst deactivation by cellular metabolites 
(especially before conjugation with the protective protein scaffold). Protein engineering has been 
used to begin to overcome these challenges by locating the ArM either on the cell surface or in the 
periplasm, both of which have lower levels of thiols compared to the cytoplasm.  
The cell surface is the most versatile location as it can be used with an ArM formed by either 
covalent or supramolecular attachment of metal complexes (Figure 3B). Mahy and Ghattas used the 
affinity of natural cell surface receptors, A2A adenosine receptors (A2 AR), for their antagonists to 
locate metal complexes on the surface of human embryonic cells (HEK) [41]. The resulting surface 
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attached ArM showed moderate activity in Cu-catalysed Diels-Alder reactions (Figure 3C). Ward and 
co-workers fused an Lpp-OmpA (Lpp: truncated lipoprotein, OmpA: the outer membrane protein A) 
fragment to both Streptavidin (Sav) and carbonic anhydrase II (CAII) so they were expressed on the 
cell surface of E.coli. Subsequent metal complex binding and use in fluorescent assays allowed for 
the genetic and chemical optimisation of the ArMs (Figure 3B) [42,43]. The Schwaneberg group used 
a different transporter, the esterase autotransporter (EstA), to locate nitrobindin (Nb) on the surface 
of E.coli which was then modified in vivo with a rhodium-maleimide complex to give a covalently 
bound ArM (Figure 3B) [44]. 
ArMs can be localised to the periplasm using either protein scaffolds that naturally locate to the 
periplasm (Figure 3D) or by the fusion of a leader sequence for periplasm localisation to the ArM 
protein scaffold gene (Figure 3E). Tezcan and co-workers used the former approach to optimise a de 
novo Zn-hydrolase by coupling the in vivo expression to the hydrolysis of the antibiotic ampicillin 
creating a live/death cell assay [45]. The Ward group have also constructed gene fusions using the N-
terminal signal peptide from OmpA to locate both Sav and CAII in the periplasm [43,46]. Addition of 
a metal complex containing a complementary supramolecular binding motif gave rise to ArMs. Using 
pro-fluorescent substrates, it was possible to optimise transfer hydrogenases.     
  
Figure 3: A: The progression from in vitro catalysis to whole cell catalysis, B: Bacterial cell surface 
display of both covalent and supramolecular ArMs [42-44], C: ArMs formed using A2 AR receptors on 
the surface of human cells[41],D: De novo ArMs for periplasmic expression 44],E: Periplasmic 
location of supramolecular ArMs [43,46]. (ArM PS: ArM protein scaffold gene) 
1.2.2 Genetic code expansion and the artificial metalloenzyme 
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Genetic code expansion (GCE) has long been of interest to biologists, but it is only in the last few 
years that chemists have applied GCE to ArM design (Figure 1E and 2B). Lewis and co-workers used 
p-azidophenylalanine (pAzF) to increase the throughput of the genetic evolution of a covalently 
bound dirhodium ArM [47]. The bioorthogonal reaction of the azide with a strained alkyne-tethered 
dirhodium complex allowed for efficient evolution of the ArM in cell lysate via random mutagenesis. 
A promising and exciting use of unnatural amino acids (UAAs), is the introduction of metal-binding 
UAAs directly into protein scaffolds, allowing the genetic incorporation of completely new abiotic 
activities into proteins. ArMs using UAAs can be directly expressed without the need to add 
synthetic metal complexes, providing an attractive approach towards ArMs for in vivo applications. 
Green, Hilvert and co-workers used amber stop codon suppression to introduce an N-methyl 
histidine into the proximal position in Mb [48]. This enabled them to convert Mb into a peroxidase. 
Following both genetic code expansion and directed evolution they obtained a highly active 
metalloenzyme that almost matched the peroxidase activity of Horse Radish Peroxidase (HRP). The 
Fasan group replaced the proximal histidine in their Mb-based carbene transferases with a range of 
UAAs known to bind metals as small molecules. However, none of the UAAs they used improved 
catalysis [49]. Roelfes and co-workers introduced bipyridyl alanine (BpyAla) into LmrR and upon 
copper binding, the resulting ArM was shown to catalyse the hydration of enones and Friedel-Crafts 
reactions (Figure 1E) [28]. Bipyridine is a common bidentate ligand in inorganic chemistry and 
transition metal catalysis therefore there are many more reactions that can be explored. This work 
opens the door to further research and the exploration of other metal-binding UAAs for the 
generation of ArMs. One challenge that needs to be overcome is how to bind the required metal in 
vivo without the purification of the protein. To successfully solve this challenge chemists and 
synthetic biologists will need to work together to understand cellular metal transport, particularly if 
non-biological metals are to be utilised. 
1.2.3 Cascade reactions for chemical synthesis 
As mentioned above one of the long-term goals in the field of ArMs is to use them in biosynthetic 
pathways (Figure 4A). A first step to show if engineered enzymes and ArMs can potentially be used 
in biosynthetic pathways is to explore them in in vitro cascades to ensure they are compatible with 
natural enzymes. The majority of reported cascades have focused on cofactor regeneration and/or 
kinetic resolution. NADPH-dependent artificial transfer hydrogenases (ATHases) have been used in 
imine reductions and coupled with multiple enzymes both to regenerate the NADPH and to improve 
the enantioselectivity of the amine product using kinetic resolution [50]. ATHases have also been 
used for the regeneration of NADP+ following its production by a NADPH-dependent enzyme [51].  
One of the hallmarks of biosynthetic pathways in cells is the exquisite control mechanisms used by 
the cell to control the spatial and temporal separation of incompatible catalysts/reagents/products.  
The extracellular location of transition metal catalysts has been successfully combined with 
biosynthetic pathways to catalyse the final step in several biosynthetic cascades (Figure 4). This 
approach has been used to make feedstock chemicals (Figure 4B) [52], small-molecule intermediates 
(Figure 4C) [53] as well as potential antibiotics (Figure 4D) [54]. Interestingly, as far as the author is 
aware no engineered metalloenzyme or ArM catalysing an abiotic reaction have been included in a 
biosynthetic pathway, even though their use in vivo has been described for both ring-closing 




Figure 4: A: The progression from in vitro cascades to biosynthetic pathways, B: Chemoenzymatic 
chemical feedstock synthesis [52], C: Combining engineered E. coli with biocompatible micelles for 
cyclopropane production [53], D: Chemoenzymatic synthesis of antibiotics using an engineered S. 
colelicolor [54]. 
Whilst ArMs have not yet been used in in vivo biosynthetic pathways for chemical synthesis, their 
use in biologically relevant cascades has been explored. Matile, Fussengger, Ward, and co-workers 
showed that a cell-penetrating Sav based ArM could be used to regulate a T3-responsive gene switch 
in HEK-293T cells by uncaging allylcarbamate-protected triiodothyronine (AT3) to give the thyroid 
hormone, T3 [55].  
Note: Whilst this paper was under review a pre-print from Hartwig and co-workers was published in 
ChemRxiv describing the use of an iridium containing P450 in the biosynthesis of an unnatural 
terpenoid. The ArM was used to cyclopropanate biosynthetically derived limonene. (Huang, J. et al. 
ChemRxiv. DOI: 10.26434/chemrxiv.11955174.v1) 
1.3 Perspectives 
The engineering of natural metalloenzymes and design of ArMs has provided the chemical and 
biological communities with new catalysts for abiotic chemical reactions. By combining this 
technology with advances in synthetic biology, applications beyond chemical production are now 
being tackled. These include targeted drug activation [56] and small molecule biosensors [57].  
Biological tools such as cell surface display have allowed the genetic evolution of ArMs, which in turn 
has improved their activity and selectivity. However, in most cases ArMs are still far less active than 
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engineered metalloenzymes hindering their widespread use. To overcome this challenge the ArM 
community needs to improve its understanding of ArM structure and catalytic mechanisms.  
To date only a small subset of ArMs have been utilised for in vivo chemical synthesis. Potential 
roadblocks in the use of ArMs in biosynthetic pathways are their incomplete genetic encodability 
and the lack of regulatory components available for ArMs that are needed to control the flow of 
substrates through a pathway. The use of transporters to carry metal complexes into the cell and the 
utilisation of metal-binding UAAs in ArM design provide stepping stones that may widen ArM use in 
vivo. In addition, several groups have started to design methods to regulate ArM activity [32, 55, 58] 
and to control metal concentration and binding in vivo [59]. As illustrated in this review the field of 
ArMs is a fast-moving and exciting area to work in. Combining the knowledge of synthetic biologists 
and biochemists with that of the chemists in the field will be vital for ensuring that ArMs reach their 
potential.  
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